⌘K

Login Start Free

Home/Filings/4/0001209191-21-042299

4//SEC Filing

White Lauren 4

Accession 0001209191-21-042299

CIK 0001662579other

View on SEC.gov Company Profile

Filed

Jun 20, 8:00 PM ET

Accepted

Jun 21, 8:22 PM ET

Size

5.4 KB

Accession

0001209191-21-042299

Insider Transaction Report

Form 4

Period: 2021-06-21

C4 Therapeutics, Inc.CCCC

Chief Financial Officer

Transactions

Award
Stock Option (Right to Buy)
2021-06-21+136,000→ 136,000 total
Exercise: $38.49Exp: 2031-06-20→ Common Stock (136,000 underlying)

Footnotes (1)

[F1]25% of this option shall vest and become exercisable on June 21, 2022, with the remainder vesting in 36 equal monthly installments thereafter.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

C4 Therapeutics, Inc.

CIK 0001662579

Entity typeother

Related Parties

1

filerCIK 0001864430

Filing Metadata

Form type: 4
Filed: Jun 20, 8:00 PM ET
Accepted: Jun 21, 8:22 PM ET
Size: 5.4 KB

View on SEC.gov